1)Clostridium difficile infection 2)Crohn disease, ulcerative colitis 3)Chronic Enteropathy associat
Conditions
Interventions
Sponsors
Ohmiya Naoki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)recipient A patient who provides the informed consent or legally acceptable representatives of whom provide the informed consent (2)donor with all negative screening tests
Exclusion criteria
Exclusion criteria: (1)recipient 1) past history of allergy to drugs used in this study 2) possible of documented pregnant women 3) judged to be inappropriate by the investigator (2)donor 1) person who is not compatible to the selection criteria 2) person with past history of allergy to drugs used in this study 3) possible of documented pregnant women 4) person with suspected or documented bowel obstruction 5) person with gastrointestinal tumors 6) person who was judged to be inappropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety in FMT | — |
Secondary
| Measure | Time frame |
|---|---|
| The effectiveness and acceptance of FMT | — |
Contacts
Public ContactNaoki Ohmiya
Fujita Health University Hospital
Outcome results
None listed